The Index
400 dossiers · 1 need attention
A research screener for every company we cover. Search a name or ticker, then sort and triage dossiers by coverage freshness, our conviction and trading relevance.
C Coherent Corpcatalyst in 43d | An II-VI/Coherent merger debt-mule reborn as the picks-and-shovels supplier of the AI-optics supercycle — backed out to 2028, Nvidia-anchored, and de-risking the balance sheet — but priced at ~49x forward EPS that already embeds flawless CPO execution it has not yet proven. | — | 0 |
| Best-in-class ag-equipment compounder at the bottom of a brutal large-ag cycle, already re-rated to ~32x on a trough-earnings recovery — the moat and the precision-ag option are real, but the price has front-run the recovery, so this is a high-quality WATCH, not a fresh entry. | — | 0 | |
| The most dangerous competitor bulls underestimate — the named beneficiary of NVIDIA's own inference-share vulnerability, growing AI +143% — but priced at a PREMIUM to NVIDIA (45× vs 30× EV/EBITDA) on one-third the ROE, with lower earnings quality (acquisition-amortization add-backs, $64B debt) and the same hyperscaler concentration. The most expensive, lowest-quality way to play the custom-silicon thesis. NEUTRAL / WATCHING / MEDIUM. | WatchingMed | ||
| A Bitmain/Antalpha-controlled reverse-merger shell wearing a Bitcoin-miner costume and now an AI-compute costume — high-cost fleet, ~50% related-party voting control, a NYSE sub-$1 delisting clock, and a balance sheet half-built on Antalpha loans; avoid the equity, watch only as a Bitmain-proxy / forced-restructuring special situation. | — | 0 | |
| The market prices Micron as a peak-cycle memory-cyclical (~9–10× forward) while it becomes a structural HBM oligopolist on multi-year contracts — a re-rating bet, not an earnings bet, with peak-cycle entry risk. BULLISH / MEDIUM / 1Y. | BullishMed | 11 |
| 11 |